NVO vs. NVAX
NVO (Novo Nordisk A/S) and NVAX (Novavax, Inc.) are both stocks. Both are in the Healthcare sector — NVO in Drug Manufacturers - General, NVAX in Biotechnology. Over the past 10 years, NVO returned 7.06%/yr vs -23.23%/yr for NVAX. At a 0.17 correlation, their price movements are largely independent.
Performance
NVO vs. NVAX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a -10.58% return, which is significantly lower than NVAX's 34.37% return. Over the past 10 years, NVO has outperformed NVAX with an annualized return of 7.06%, while NVAX has yielded a comparatively lower -23.23% annualized return.
NVO
- 1D
- 2.69%
- 1M
- -6.47%
- YTD
- -10.58%
- 6M
- -9.53%
- 1Y
- -41.56%
- 3Y*
- -15.73%
- 5Y*
- 2.96%
- 10Y*
- 7.06%
NVAX
- 1D
- 5.49%
- 1M
- -6.13%
- YTD
- 34.37%
- 6M
- 34.98%
- 1Y
- 27.36%
- 3Y*
- 5.09%
- 5Y*
- -46.69%
- 10Y*
- -23.23%
NVO vs. NVAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | -10.58% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
NVAX Novavax, Inc. | 34.37% | -16.42% | 67.50% | -53.31% | -92.81% | 28.30% | 2,701.76% | -89.18% | 48.39% | -1.59% |
Correlation
The correlation between NVO and NVAX is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Dec 13, 1995 | 0.17 |
The correlation between NVO and NVAX shifts across timeframes, from 0.17 (all time) to 0.34 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
NVO:
$195.56B
NVAX:
$1.47B
NVO:
DKK 27.42
NVAX:
-$0.52
NVO:
3.86
NVAX:
2.56
NVO:
DKK 327.80B
NVAX:
$596.34M
NVO:
DKK 268.30B
NVAX:
$504.72M
NVO:
DKK 181.54B
NVAX:
-$57.01M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. NVAX — Risk / Return Rank
NVO
NVAX
NVO vs. NVAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | NVAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.20 | ||
| Sortino ratioReturn per unit of downside risk | -2.12 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.13 | -0.27 |
| Calmar ratioReturn relative to maximum drawdown | -0.76 | 0.76 | -1.52 |
| Martin ratioReturn relative to average drawdown | -1.11 | 1.49 | -2.59 |
Loading charts...
Drawdowns
NVO vs. NVAX - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, smaller than the maximum NVAX drawdown of -98.82%. Use the drawdown chart below to compare losses from any high point for NVO and NVAX.
Loading charts...
Drawdown Indicators
| NVO | NVAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -98.82% | +24.12% |
Max Drawdown (1Y)Largest decline over 1 year | -55.03% | -35.94% | -19.09% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -74.11% | -0.59% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -98.61% | +23.91% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -98.82% | +24.12% |
Current DrawdownCurrent decline from peak | -68.06% | -97.18% | +29.12% |
Average DrawdownAverage peak-to-trough decline | -17.78% | -70.76% | +52.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.52% | 18.46% | +19.06% |
Volatility
NVO vs. NVAX - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 10.69%, while Novavax, Inc. (NVAX) has a volatility of 23.98%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than NVAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | NVAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.69% | 23.98% | -13.29% |
Volatility (6M)Calculated over the trailing 6-month period | 38.46% | 52.24% | -13.78% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.88% | 68.90% | -17.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.34% | 106.10% | -67.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.56% | 115.50% | -82.94% |
Dividends
NVO vs. NVAX - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 4.10%, while NVAX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVAX Novavax, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 4.10% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. NVAX - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVO vs. NVAX - Profitability Comparison
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
NVAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novavax, Inc. reported a gross profit of 108.82M and revenue of 139.51M. Therefore, the gross margin over that period was 78.0%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
NVAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novavax, Inc. reported an operating income of -15.43M and revenue of 139.51M, resulting in an operating margin of -11.1%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
NVAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novavax, Inc. reported a net income of -9.49M and revenue of 139.51M, resulting in a net margin of -6.8%.
Frequently Asked Questions
NVO and NVAX have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVAX has higher volatility (23.98%) compared to NVO (10.69%). In terms of maximum drawdown, NVO dropped -74.70% vs NVAX's -98.82%.
NVAX currently has the higher Sharpe Ratio (0.40 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and NVAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer